NBA Clears Pwani University For Advanced Biotechnology Research
For Pwani University, the new certification provides an important foundation for expanding its biotechnology research activities while ensuring that scientists operate within the country’s established regulatory framework.
By Staff Writer
Kenya’s biotechnology research capacity has received a boost following the certification of Pwani University’s Biosciences Research Centre by the National Biosafety Authority, paving the way for the institution to undertake advanced research involving genetically modified organisms under regulated conditions.
The certification of the Pwani University Biosciences Research Centre (PUBReC) as a Biosafety Level II (BSL-2) containment facility marks an important development in the country’s efforts to expand scientific research, strengthen institutional capacity and promote innovation in modern biotechnology.
Biosafety Level 2 (BSL-2) is a laboratory containment standard designed for handling biological agents that pose moderate risks to personnel and the surrounding environment. It applies to clinical, diagnostic and teaching laboratories working with agents associated with diseases that are generally treatable or preventable.
The approval allows the university to undertake regulated biotechnology research activities, including genetic transformation and other laboratory-based studies, subject to the relevant regulatory requirements and approvals.
The certification was announced earlier today following an assessment by the National Biosafety Authority (NBA), the government agency responsible for regulating activities involving genetically modified organisms (GMOs) in Kenya.
Speaking on the certification, NBA Acting Chief Executive Officer Dr. Ann Karimi said the university had met the requirements for handling and using GMOs in research under the prescribed biosafety standards.
“This was achieved after the University satisfied the criteria for BSL requirements for safe handling and use of GMOs under research. It’s for one year thereafter requiring a reinspection and recertification annually for continued compliance,” said Karimi.
The certification is valid for one year, after which the facility must undergo another inspection and obtain recertification to demonstrate continued compliance with the required safety standards.
The development places Pwani University among institutions with approved facilities for conducting regulated biotechnology research in Kenya. Other active registered research facilities include the International Livestock Research Institute (ILRI) laboratory involved in GMO research, as well as the Kenya Agricultural and Livestock Research Organization (KALRO) biotechnology and Njoro laboratories.
The certification is significant as Kenya continues to strengthen its biotechnology research infrastructure, with universities and research institutions required to demonstrate compliance with national biosafety standards before undertaking activities involving genetically modified organisms.
Kenya’s biotechnology research activities are regulated under the Biosafety Act, 2009, which established the National Biosafety Authority to oversee the development, transfer, handling and use of genetically modified organisms.
The law seeks to facilitate responsible scientific research while minimizing potential risks to human and animal health and protecting the environment.
Under Section 18(1) of the Act, conducting activities involving GMOs without written authorization from the Authority is prohibited. Such activities include contained research, confined field trials, environmental releases, and the importation, exportation and transit of genetically modified organisms.
Institutions undertaking GMO-related research are also required to establish an Institutional Biosafety Committee (IBC), a multidisciplinary body responsible for overseeing biosafety compliance within the institution and serving as its official liaison with the NBA.
The committees assess proposed research activities, advise scientists on biosafety requirements, review risk assessments and ensure that appropriate containment and monitoring measures are in place.
Under the Biosafety (Contained Use) Regulations, 2011, research involving GMOs must be conducted in appropriately approved and certified facilities, with the required level of containment determined by the nature and potential risks of the activities.
Laboratory, greenhouse and other contained GMO research must receive the relevant written approval from the NBA before commencement. Researchers submit applications through their institutional biosafety committees for regulatory assessment.
The regulatory framework also addresses emerging technologies, including genome editing, which enables scientists to make targeted changes to an organism’s genetic material.
Researchers intending to use gene-editing technologies are required to seek early consultation with the NBA to establish whether the resulting organism falls within the scope of existing GMO regulations and determine the applicable approval process.
The Authority provides separate regulatory pathways for contained use, confined field trials and environmental release, depending on the nature and intended application of the research.
Its online regulatory services also facilitate applications for institutional biosafety committee registration, approval of research facilities, contained-use activities and environmental release of genetically modified organisms.
The certification of Pwani University’s facility comes as Kenya continues to invest in strengthening institutional capacity and regulatory oversight in biotechnology research.
In January 2026, the NBA conducted capacity-building training for KALRO’s Institutional Biosafety Committee to strengthen its ability to assess, monitor and oversee research involving genetically modified organisms.
The training focused on risk assessment, biosafety monitoring, reporting and compliance with national regulations and international biosafety standards.
The NBA’s regulatory mandate is also aligned with Kenya’s obligations under the Cartagena Protocol on Biosafety, an international agreement that seeks to ensure the safe handling, transfer and use of living modified organisms that may pose risks to biodiversity, while taking into account potential risks to human health.
For Pwani University, the new certification provides an important foundation for expanding its biotechnology research activities while ensuring that scientists operate within the country’s established regulatory framework.
The annual inspection and recertification requirement will also ensure that the facility continues to meet the necessary containment and safety standards as it undertakes approved research projects.


